RIPK1 and cancer: Considering the advantageous effects of chemotherapy in promoting cancer cells apoptosis, PDAC-bearing mice were initially treated with gemcitabine for a similar impact on necroptosis, thereby confirming that chemotherapy increased expression of RIPK1/3 in vivo.